Showing results (2931-2940 of 4,783) with videos related to

Sort By:
Pageof 479
Drug Discovery Today|December 12, 2018
TGFβ and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertensionBirger Tielemans, Marion Delcroix, Catharina Belge, et al.
Drug Discovery Today|February 1, 2019
Fullerene-based delivery systemsHouman Kazemzadeh, Masoud Mozafari
Drug Discovery Today|February 17, 2020
The quest for the holy grail: new antitubercular chemical entities, targets and strategiesStanislav Huszár, Kelly Chibale, Vinayak Singh
Drug Discovery Today|February 17, 2020
Is cannabidiol a scheduled controlled substance? Origin makes the differenceCinzia Citti, Pasquale Linciano, Giuseppe Cannazza
Drug Discovery Today|January 12, 2020
Key indicators of phase transition for clinical trials through machine learningFelipe Feijoo, Michele Palopoli, Jen Bernstein, et al.
Drug Discovery Today|January 12, 2020
An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principlesDhaval R Kalaria, Keith Parker, Gavin K Reynolds, et al.
Drug Discovery Today|January 29, 2020
Frequent hitters: nuisance artifacts in high-throughput screeningZi-Yi Yang, Jun-Hong He, Ai-Ping Lu, et al.
Drug Discovery Today|February 4, 2019
Development of long-acting recombinant glycoprotein hormones by increasing the carbohydrate contentFuad Fares, Naiel Azzam
Drug Discovery Today|February 8, 2019
Müller cells as a target for retinal therapyJoke Devoldere, Karen Peynshaert, Stefaan C De Smedt, et al.
Drug Discovery Today|January 29, 2019
Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathyOdunayo O Mugisho, Colin R Green, Jie Zhang, et al.
Pageof 479